Literature DB >> 11763497

Pulsatile drug-delivery systems.

T Bussemer1, I Otto, R Bodmeier.   

Abstract

Delivery systems with a pulsatile-release pattern are receiving increasing interest for the development of drugs for which conventional controlled drug-release systems with a continuous release are not ideal. These drugs often have a high first-pass effect or special chronopharmacological needs. A pulsatile-release profile is characterized by a time period of no release (lag time) followed by a rapid and complete drug release. Pulsatile drug-delivery systems can be classified into site-specific systems in which the drug is released at the desired site within the intestinal tract (e.g., the colon), or time-controlled devices in which the drug is released after a well-defined time period. Site-controlled release is usually controlled by environmental factors, like the pH or enzymes present in the intestinal tract, whereas the drug release from time-controlled systems is controlled primarily by the delivery system and, ideally, not by the environment. This review covers various single- and multiple-unit oral pulsatile drug-delivery systems with an emphasis on time-controlled drug-release systems.

Mesh:

Substances:

Year:  2001        PMID: 11763497

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  14 in total

1.  Colon targeted drug delivery systems: a review on primary and novel approaches.

Authors:  Anil K Philip; Betty Philip
Journal:  Oman Med J       Date:  2010-04

2.  Interchangeability, Safety and Efficacy of Modified-Release Drug Formulations in the USA: The Case of Opioid and Other Nervous System Drugs.

Authors:  Enrique Seoane-Vazquez; Rosa Rodriguez-Monguio; Richard Hansen
Journal:  Clin Drug Investig       Date:  2016-04       Impact factor: 2.859

3.  Equivalence-by-design: targeting in vivo drug delivery profile.

Authors:  Mei-Ling Chen; Vincent H L Lee
Journal:  Pharm Res       Date:  2008-10-28       Impact factor: 4.200

4.  A novel injection-molded capsular device for oral pulsatile delivery based on swellable/erodible polymers.

Authors:  Andrea Gazzaniga; Matteo Cerea; Alberto Cozzi; Anastasia Foppoli; Alessandra Maroni; Lucia Zema
Journal:  AAPS PharmSciTech       Date:  2011-01-26       Impact factor: 3.246

5.  Hydrophilic excipients modulate the time lag of time-controlled disintegrating press-coated tablets.

Authors:  Shan-Yang Lin; Mei-Jane Li; Kung-Hsu Lin
Journal:  AAPS PharmSciTech       Date:  2004-08-16       Impact factor: 3.246

6.  Pulsatile protein release from monodisperse liquid-core microcapsules of controllable shell thickness.

Authors:  Yujie Xia; Daniel W Pack
Journal:  Pharm Res       Date:  2014-05-16       Impact factor: 4.200

7.  Mucus-Penetrating Nanosuspensions for Enhanced Delivery of Poorly Soluble Drugs to Mucosal Surfaces.

Authors:  Tao Yu; Jane Chisholm; Woo Jin Choi; Abraham Anonuevo; Sarah Pulicare; Weixi Zhong; Minmin Chen; Colleen Fridley; Samuel K Lai; Laura M Ensign; Jung Soo Suk; Justin Hanes
Journal:  Adv Healthc Mater       Date:  2016-09-26       Impact factor: 9.933

Review 8.  Micro Electromechanical Systems (MEMS) Based Microfluidic Devices for Biomedical Applications.

Authors:  Muhammad Waseem Ashraf; Shahzadi Tayyaba; Nitin Afzulpurkar
Journal:  Int J Mol Sci       Date:  2011-06-07       Impact factor: 5.923

Review 9.  Recent technologies in pulsatile drug delivery systems.

Authors:  Deepika Jain; Richa Raturi; Vikas Jain; Praveen Bansal; Ranjit Singh
Journal:  Biomatter       Date:  2011 Jul-Sep

10.  Formulation and evaluation of multiparticulate system for chronotherapeutic delivery of salbutamol sulphate.

Authors:  Pallavi M Chaudhari; Pravin D Chaudhari
Journal:  J Pharm Bioallied Sci       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.